A new method for the manufacture of bis(4-aminophenyl)-sulfone and the anti-leprosy, anti-tuberculosis, and antibiotic activities of some new derivatives related to the drug. I.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000995:Antitubercular Agents / Q000627:therapeutic use*; D001205:Ascorbic Acid / Q000627:therapeutic use; D001419:Bacteria / Q000187:drug effects*; D002771:Cholera / Q000188:drug therapy; D003622:Dapsone / Q000138:chemical synthesis*; D004405:Dysentery, Bacillary / Q000188:drug therapy; D005260:Female; D006571:Heterocyclic Compounds / Q000627:therapeutic use; D006801:Humans; D007918:Leprosy / Q000188:drug therapy*; D008581:Meningitis / Q000188:drug therapy; D008583:Meningitis, Haemophilus / Q000188:drug therapy; D008722:Methods; D010038:Otorhinolaryngologic Diseases / Q000188:drug therapy; D011247:Pregnancy; D011645:Puerperal Infection / Q000188:drug therapy; D012541:Scarlet Fever / Q000188:drug therapy; D013432:Sulfathiazoles / Q000627:therapeutic use; D013450:Sulfones / Q000627:therapeutic use*; D014390:Tuberculosis, Meningeal / Q000188:drug therapy; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy; D014552:Urinary Tract Infections / Q000188:drug therapy; D014812:Vitamin K / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents; D006571:Heterocyclic Compounds; D013432:Sulfathiazoles; D013450:Sulfones; D014812:Vitamin K; D003622:Dapsone; D001205:Ascorbic Acid